drugs
According to a new study published on Thursday, the psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder. The company sponsoring the research, MAPS Public Benefit Corporation, said it plans to seek U.S. approval to market the drug at the end of the year. “It’s the first innovation in PTSD treatment in more than two decades,” said CEO of MAPS Public Benefit Corporation Amy Emerson in a statement. “And it’s significant because I think it will also open up other innovations.” To conduct the study, researchers examined the symptoms of 104 patients with PTSD, some of whom wer...
uInterview.com
California could soon become the third state to decriminalize psychedelics after the state assembly passed a bill that would allow adults 21 and older to legally possess the drug in both plant and mushroom form. Introduced by State Sen. Scott Weiner in 2021, Senate Bill 58 was passed in a 42-11 vote. It would decriminalize substances such as psilocybin, DMT and hallucinogenic mushrooms. Those who support the decriminalization and legalization of psychedelic drugs say it has mental health benefits by reducing symptoms of major depressive disorder. Recent surveys show a growing nationwide suppor...
uInterview.com
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら